Company completes spin-off of seed business, well positioned to advance its robust pipeline with 12 new actives, including 5 biologicals, for launch in the next decade

INDIANAPOLIS—Oct. 1, 2026 – Corteva, Inc. (NYSE: CTVA) today announced it has successfully spun off its advanced seed and genetics business and will move forward as a leading, pure-play global crop protection company.

“This is a new day for Corteva, and we couldn’t be more excited as we move forward with greater focus, agility and a renewed commitment to innovation and operational excellence,” said Corteva CEO Luke Kissam. “As the challenges facing agriculture continue to evolve, we’re ready to meet the needs of the future with the industry’s best people, portfolio and pipeline—advancing safe, effective and sustainable solutions that
deliver for farmers, our channel partners and our shareholders.”

Corteva begins this next chapter with strong momentum and a proven record of excellence in execution. Between 2020 and 2025, the crop protection business increased revenue by over $1 billion while expanding operating EBITDA margins by approximately 250 basis points on a segment basis. This progress includes establishment of an industry-leading biologicals and natural products platform, and intentional evolution of the company’s product mix toward differentiated technologies—now representing ~65% of sales—to bring new, critically-needed innovations to farmers.

With an $11 billion crop protection pipeline, world-class R&D capabilities, including our microbial discovery, integrated development, and predictive safety platforms, Corteva’s future growth will be driven by innovation farmers need most. Today, the company’s nearly 9,000 employees serve growers in approximately 110 countries.